,mean_rank,weight
cervix,12.0,3.0
lung carcinoma,14.0,1.0
small cell lung carcinoma,32.5,88.0
pancreatic somatostatinoma,48.0,3.0
adrenal gland,48.0,3.0
endometrioid stromal sarcoma,51.0,3.0
medulloblastoma,57.0,8.0
cervical small cell carcinoma,63.0,1.0
lung carcinoid tumor,63.5,6.0
adrenal gland neuroblastoma,65.0,5.0
embryonal carcinoma,69.0,1.0
neuroblastoma,69.0,52.0
vertebra,83.0,2.0
multiple endocrine neoplasia type 2,85.0,1.0
hereditary thyroid gland medullary carcinoma,85.0,1.0
prostate carcinoma,88.0,11.0
supraclavicular lymph node,89.0,3.0
right thigh skin,91.5,2.0
testicular embryonal carcinoma,97.0,1.0
skin nodule,98.0,1.0
thyroid gland squamous cell carcinoma,99.0,3.0
brain,113.0,16.0
uterine carcinosarcoma,115.0,2.0
natural killer cell lymphoblastic leukemia/lymphoma,122.0,1.0
pharyngeal squamous cell carcinoma,123.0,3.0
invasive lobular breast carcinoma,134.0,1.0
right anterior leg,135.0,3.0
not specified,141.0,3.0
inguinal lymph node,143.0,3.0
salivary gland squamous cell carcinoma,143.0,3.0
rhabdomyosarcoma,151.0,4.0
high grade ovarian serous adenocarcinoma,152.5,40.0
ovarian carcinoma,154.0,6.0
gastric choriocarcinoma,156.0,1.0
mediastinal lymph node,166.0,1.0
ewing sarcoma,168.0,31.0
thoracic lymph duct,170.0,1.0
peritoneal ascites,180.0,2.0
duodenal adenocarcinoma,181.0,1.0
gastric small cell neuroendocrine carcinoma,181.5,4.0
lymphoma,183.0,1.0
myeloid leukemia associated with down syndrome,184.0,1.0
lung mucoepidermoid carcinoma,186.0,3.0
pelvic wall,188.0,3.0
thigh skin,188.0,1.0
embryonal rhabdomyosarcoma,189.5,6.0
large cell lung carcinoma,198.5,32.0
minimally invasive lung adenocarcinoma,200.5,16.0
right pararenal lymph node,201.0,2.0
abdomen,201.5,2.0
oligodendroglioma,202.0,5.0
thyroid gland follicular carcinoma,202.0,10.0
brca1 syndrome,204.0,1.0
gestational choriocarcinoma,208.5,2.0
axillary lymph node,209.5,6.0
osteosarcoma,211.0,23.0
subserosa of fallopian tube,212.0,1.0
ovarian serous adenocarcinoma,219.0,7.0
brca2 syndrome,220.0,1.0
groin lymph node,221.0,5.0
bone marrow,223.0,65.0
ovarian endometrioid adenocarcinoma,231.0,11.0
alveolar rhabdomyosarcoma,232.0,9.0
squamous cell lung carcinoma,240.5,48.0
endometrial carcinoma,247.0,8.0
intrahepatic cholangiocarcinoma,248.0,6.0
adenosquamous lung carcinoma,248.0,9.0
supra-orbital region,249.0,1.0
ovarian granulosa cell tumor,253.0,2.0
papillary renal cell carcinoma,260.0,5.0
neurofibromatosis type 1,267.0,1.0
laryngeal squamous cell carcinoma,267.0,12.0
cutaneous melanoma,268.0,26.0
primitive neuroectodermal tumor,269.5,2.0
subcutaneous,270.0,7.0
vaginal melanoma,271.0,1.0
lung giant cell carcinoma,271.5,4.0
pleural epithelioid mesothelioma,272.5,18.0
gastric adenosquamous carcinoma,273.0,2.0
melanoma,274.0,94.0
undifferentiated gallbladder carcinoma,276.0,1.0
ovarian mixed germ cell tumor,279.0,1.0
spleen,281.0,3.0
amelanotic melanoma,288.5,16.0
bronchogenic carcinoma,288.5,2.0
abdominal wall,291.0,2.0
endometrial adenosquamous carcinoma,294.0,6.0
breast carcinoma,296.0,27.0
tonsillar squamous cell carcinoma,302.0,1.0
squamous papilloma,304.0,1.0
left leg muscle,306.0,3.0
clear cell renal cell carcinoma,307.5,18.0
down syndrome,310.0,2.0
cerebrospinal fluid,312.0,3.0
hepatocellular carcinoma,314.0,51.0
ovarian leiomyosarcoma,314.0,3.0
bladder squamous cell carcinoma,316.0,3.0
right axillary lymph node,316.0,1.0
omentum,318.0,7.0
n/a,321.5,34.0
ovarian serous cystadenocarcinoma,322.0,4.0
pleural effusion,329.0,224.0
renal cell carcinoma,330.0,37.0
pancreatic carcinoma,332.0,12.0
lymph node,339.0,105.0
hypopharyngeal squamous cell carcinoma,344.0,5.0
glioblastoma,349.0,84.0
cervical lymph node,349.0,5.0
pleural sarcomatoid mesothelioma,349.5,8.0
ovarian adenocarcinoma,351.0,5.0
ascites,351.0,103.0
bladder carcinoma,351.0,51.0
esophageal squamous cell carcinoma,352.0,59.0
thyroid gland undifferentiated (anaplastic) carcinoma,359.0,13.0
chronic lymphocytic leukemia,360.5,2.0
lung adenocarcinoma,361.0,145.0
poorly differentiated thyroid gland carcinoma,363.0,3.0
celiac axis lymph node,363.5,2.0
pelvis; innominate bone,368.0,2.0
small intestine,369.0,1.0
oral cavity squamous cell carcinoma,371.0,6.0
hodgkin lymphoma,374.0,11.0
astrocytoma,375.0,19.0
ovarian cystadenocarcinoma,377.5,6.0
intraperitoneal,379.0,1.0
erythroleukemia,381.0,3.0
chondrosarcoma,382.0,10.0
plasma cell myeloma,382.5,30.0
"invasive ductal carcinoma, not otherwise specified",384.5,30.0
adult acute monocytic leukemia,391.0,5.0
"squamous cell breast carcinoma, acantholytic variant",392.0,3.0
liposarcoma,397.0,1.0
acute myeloid leukemia,398.0,1.0
ductal breast carcinoma,398.5,32.0
breast adenocarcinoma,399.0,23.0
gingival squamous cell carcinoma,402.0,2.0
anaplastic large cell lymphoma,410.0,8.0
ovarian mucinous adenocarcinoma,410.5,4.0
childhood acute myeloid leukemia with maturation,411.0,1.0
gastric carcinoma,412.0,12.0
gastric tubular adenocarcinoma,416.0,11.0
peritoneum,418.0,1.0
mucinous gastric adenocarcinoma,419.0,3.0
tongue squamous cell carcinoma,419.5,34.0
pleural biphasic mesothelioma,421.0,7.0
marek disease,422.0,1.0
ovarian clear cell adenocarcinoma,423.0,13.0
pancreatic adenosquamous carcinoma,429.0,5.0
recurrent bladder carcinoma,433.0,3.0
gliosarcoma,435.5,6.0
gastric adenocarcinoma,437.5,26.0
ovarian mucinous cystadenocarcinoma,438.5,2.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",439.0,2.0
b-cell non-hodgkin lymphoma,445.0,7.0
non-small cell lung carcinoma,451.0,24.0
childhood t acute lymphoblastic leukemia,452.0,19.0
hepatoblastoma,452.5,4.0
mantle cell lymphoma,453.0,6.0
pancreatic adenocarcinoma,453.0,39.0
rectal adenocarcinoma,453.0,11.0
subcutaneous; right buttock,454.0,3.0
rhabdoid tumor of the kidney,456.0,3.0
endometrial adenocarcinoma,456.5,34.0
vulvar leiomyosarcoma,457.0,3.0
thyroid gland sarcoma,458.0,1.0
lung,459.0,7.0
peripheral blood,460.0,107.0
epithelioid cell type gastrointestinal stromal tumor,460.0,3.0
liver,462.0,32.0
gallbladder carcinoma,464.0,2.0
colon adenocarcinoma,464.0,61.0
malignant ovarian brenner tumor,468.0,1.0
gastric fundus carcinoma,473.0,1.0
ampulla of vater adenocarcinoma,474.0,2.0
myelodysplastic syndrome,475.0,1.0
rectosigmoid adenocarcinoma,479.0,3.0
buttock,479.5,2.0
diffuse large b-cell lymphoma activated b-cell type,483.0,1.0
childhood acute myeloid leukemia,483.5,2.0
cecum adenocarcinoma,484.5,18.0
pericardial effusion,485.0,8.0
adrenal cortex carcinoma,491.0,1.0
colon carcinoma,503.0,19.0
papillary lung adenocarcinoma,503.0,3.0
biphasic synovial sarcoma,504.0,1.0
brachialis muscle,508.0,3.0
paragastric lymph node,511.5,2.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,515.0,1.0
askin tumor,516.5,2.0
skin squamous cell carcinoma,517.0,1.0
pancreatic ductal adenocarcinoma,522.0,39.0
signet ring cell gastric adenocarcinoma,530.0,9.0
left supraclavicular lymph node,534.0,4.0
cutaneous t-cell non-hodgkin lymphoma,535.0,2.0
skin,535.0,3.0
uterine corpus sarcoma,536.0,3.0
mandible,541.0,1.0
cervical squamous cell carcinoma,547.0,1.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",551.0,2.0
familial adenomatous polyposis,553.0,1.0
childhood t lymphoblastic lymphoma,555.0,2.0
benign prostatic hyperplasia,557.0,1.0
b-cell prolymphocytic leukemia,563.0,2.0
adult t acute lymphoblastic leukemia,567.0,5.0
fibrosarcoma,570.0,5.0
"chronic myelogenous leukemia, bcr-abl1 positive",574.5,16.0
head and neck squamous cell carcinoma,576.0,9.0
epstein-barr virus-related burkitt lymphoma,585.0,10.0
hilar cholangiocarcinoma,591.0,1.0
human papillomavirus-related cervical squamous cell carcinoma,592.5,8.0
"chronic eosinophilic leukemia, not otherwise specified",596.0,1.0
obturator lymph node,600.0,3.0
barrett adenocarcinoma,602.0,3.0
vulvar squamous cell carcinoma,608.0,3.0
mediastinal (thymic) large b-cell lymphoma,612.0,1.0
buccal mucosa squamous cell carcinoma,615.5,2.0
parotid gland mucoepidermoid carcinoma,619.0,1.0
diffuse large b-cell lymphoma germinal center b-cell type,620.0,8.0
burkitt lymphoma,621.0,8.0
peritoneal effusion,627.0,6.0
mycosis fungoides and sezary syndrome,628.0,2.0
childhood acute monocytic leukemia,642.5,2.0
esophageal adenocarcinoma,643.0,9.0
undifferentiated pleomorphic sarcoma,646.0,4.0
b acute lymphoblastic leukemia,648.0,5.0
human papillomavirus-related endocervical adenocarcinoma,655.0,4.0
cystic fibrosis,668.0,2.0
pyriform fossa squamous cell carcinoma,668.0,1.0
hairy cell leukemia,672.0,3.0
adult acute myeloid leukemia,677.0,22.0
oral dysplasia,684.0,1.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),688.5,4.0
vulvar carcinoma,693.0,1.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,702.0,3.0
cholangiocarcinoma,722.5,2.0
diffuse large b-cell lymphoma,723.0,20.0
childhood b acute lymphoblastic leukemia,740.0,9.0
lymphoblastic lymphoma,743.0,1.0
uterine corpus leiomyosarcoma,754.0,3.0
hereditary spherocytosis,758.0,1.0
primary effusion lymphoma,759.0,3.0
squamous cell carcinoma,760.0,1.0
ovary,763.0,1.0
floor of mouth squamous cell carcinoma,766.0,1.0
cervical carcinoma,768.0,2.0
pleural malignant mesothelioma,775.0,5.0
bone,781.0,1.0
anaplastic astrocytoma,819.0,5.0
splenic lymphoma with circulating villous lymphocytes,827.0,1.0
adult b acute lymphoblastic leukemia,835.0,3.0
left cervical lymph node,850.0,1.0
thyroid gland papillary carcinoma,850.0,1.0
follicular lymphoma,905.0,2.0
epithelioid sarcoma,906.0,1.0
vulvar melanoma,932.0,1.0
meninges,954.0,1.0
acute myelomonocytic leukemia,954.0,1.0
